Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management

References

• Rosenblum A, Magura S, Palij M, Foote J, Handelsman L, Stimmel B. Enhanced treatment outcomes for cocaine‐using methadone patients. Drug Alcohol Depend 5‐3‐1999; 54(3)207–218
   PubMed Web of Science ®Google Scholar
• DeMaria P A, Jr, Sterling R, Weinstein S P. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. Am J Addict 2000; 9(2)145–153
   PubMed Web of Science ®Google Scholar
• Rounsaville B J, Tierney T, Crits‐Christoph K, Weissman M M, Kleber H D. Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Compr Psychiatry 1982; 23(5)462–478
   PubMedGoogle Scholar
• Compton W M, III, Cottler L B, Ben Abdallah A, Phelps D L, Spitznagel E L, Horton J C. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addict 2000; 9(2)113–125
   PubMed Web of Science ®Google Scholar
• Myers J K, Weissman M M, Tischler G L, Holzer C E, III, Leaf P J, Orvaschel H, Anthony J C, Boyd J H, Burke J D, Jr, Kramer M. Six‐month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 1984; 41(10)959–967
   PubMed Web of Science ®Google Scholar
• Rounsaville B J, Anton S F, Carroll K, Budde D, Prusoff B A, Gawin F. Psychiatric diagnoses of treatment‐seeking cocaine abusers. Arch Gen Psychiatry 1991; 48(1)43–51
   PubMed Web of Science ®Google Scholar
• Uslaner J, Kalechstein A, Richter T, Ling W, Newton T. Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am J Psychiatry 1999; 156(9)1444–1446
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Brown S, Babb D A, Hatsukami D K. Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend 7‐1‐2001; 63(2)131–137
   PubMed Web of Science ®Google Scholar
• Gawin F H, Kleber H D, Byck R, Rounsaville B J, Kosten T R, Jatlow P I, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46(2)117–121
   PubMed Web of Science ®Google Scholar
• Arndt I, Dorozynsky L, Woody G, McLellan A T, O'Brien C P. Desipramine treatment of cocaine abuse in methadone maintenance patients. NIDA Res Monogr 1989; 95: 322–323
   PubMedGoogle Scholar
• Kosten T R, Schumann B, Wright D, Carney M K, Gawin F H. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry 1987; 48(11)442–444
   PubMed Web of Science ®Google Scholar
• Kosten T, Gawin F H, Silverman D G, Fleming J, Compton M, Jatlow P, Byck R. Intravenous cocaine challenges during desipramine maintenance. Neuropsychopharmacology 1992; 7(3)169–176
   PubMedGoogle Scholar
• Ziedonis D M, Kosten T R. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoact Drugs 1991; 23(4)417–425
   PubMed Web of Science ®Google Scholar
• Giannini A J, Malone D A, Giannini M C, Price W A, Loiselle R H. Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J Clin Pharmacol 1986; 26(3)211–214
   PubMedGoogle Scholar
• Carroll K M. Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. [Review] [70 refs.]. Addict Behav 1997; 22(2)233–245
   PubMed Web of Science ®Google Scholar
• Kosten T R, Falcioni J, Oliveto A, Feingold A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. Amer J on Addict, (in press)
   Google Scholar
• Silverman K, Higgins S T, Brooner R K, Montoya I D, Cone E J, Schuster C R, Preston K L. Sustained cocaine abstinence in methadone maintenance patients through voucher‐based reinforcement therapy. Arch Gen Psychiatry 1996; 53(5)409–415
   PubMed Web of Science ®Google Scholar
• Silverman K, Chutuape M A, Bigelow G E, Stitzer M L. Voucher‐based reinforcement of cocaine abstinence in treatment‐resistant methadone patients: effects of reinforcement magnitude. Psychopharmacologia 1999; 146(2)128–138
   PubMed Web of Science ®Google Scholar
• Dallery J, Silverman K, Chutuape M A, Bigelow G E, Stitzer M L. Voucher‐based reinforcement of opiate plus cocaine abstinence in treatment‐resistant methadone patients: effects of reinforcer magnitude. Exp Clin Psychopharmacol 2001; 9(3)317–325
   PubMed Web of Science ®Google Scholar
• Downey K K, Helmus T C, Schuster C R. Treatment of heroin‐dependent poly‐drug abusers with contingency management and buprenorphine maintenance. Exp Clin Psychopharmacol 2000; 8(2)176–184
   PubMed Web of Science ®Google Scholar
• Griffith J D, Rowan‐Szal G A, Roark R R, Simpson D D. Contingency management in outpatient methadone treatment: a meta‐analysis. Drug Alcohol Depend 2‐1‐2000; 58(1–2)55–66
   PubMed Web of Science ®Google Scholar
• Brannon S E, Nelson R O. Contingency management treatment of outpatient unipolar depression: a comparison of reinforcement and extinction. J Consult Clin Psychol 1987; 55(1)117–119
   PubMedGoogle Scholar
• Kosten T R, Oliveto A, Feingold A, Poling J, Sevarino K, McCance‐Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contigency management for cocaine and opiate dependence in buprenorphine mantained patients. Drug Alcohol Depend 2003; 70: 315–325
   PubMed Web of Science ®Google Scholar
• First M B, Spitzer R L, Gibbon M, Williams J BW. Structured Clinical Interview for DSM‐IV. American Psychiatric Association Press, Washington, DC 1995
   Google Scholar
• Kosten T R, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. [see comments]. J Nerv Ment Dis 1993; 181(6)358–364
   PubMed Web of Science ®Google Scholar
• Kosten T R, Morgan C M, Falcione J, Schottenfeld R S. Pharmacotherapy for cocaine‐abusing methadone‐maintained patients using amantadine or desipramine. Arch Gen Psychiatry 1992; 49(11)894–898
   PubMed Web of Science ®Google Scholar
• McLellan A T, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9(3)199–213
   PubMed Web of Science ®Google Scholar
• McLellan A T, Luborsky L, Woody G E, O'Brien C P. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis 1980; 168(1)26–33
   PubMed Web of Science ®Google Scholar
• Radloff L S. A CES‐D Scale: a self‐reported depression scale for reaserch in the general population. Appl Psychol Meas 1977; I: 385–401
   Web of Science ®Google Scholar
• Hamilton M A. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Proelss H F, Lohmann H J, Miles D G. High‐performance liquid‐chromatographic simultaneous determination of commonly used tricyclic antidepressants. Clin Chem 1978; 24(11)1948–1953
   PubMedGoogle Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc [A] 1972; 135: 185–207
   Web of Science ®Google Scholar
• Bryk A S, Raudenbush S W. Application of heirarchical linear models to assessing change. Psychol Bull 1987; 101: 147–158
   Web of Science ®Google Scholar
• Gibbons R D, Hedeker D, Elkin I, Waternaux C, Krarmer H C, Greenhouse J B, Shea M T, Imber S D, Sotsky S M, Watkins J T. Some conceptual and statistical issues in analyses of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50: 739–750
   PubMed Web of Science ®Google Scholar
• Kosten T R, Gawin F H, Morgan C, Nelson J C, Jatlow P. Evidence for altered desipramine disposition in methadone‐maintained patients treated for cocaine abuse. Am J Drug Alcohol Abuse 1990; 16(3–4)329–336
   PubMed Web of Science ®Google Scholar
• Weiss R D. Relapse to cocaine abuse after initiating desipramine treatment. JAMA 11‐4‐1988; 260(17)2545–2546
   PubMed Web of Science ®Google Scholar